SCM
SRNE

Sio Capital Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Sio Capital Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-184,720
Closed -$1.86M – 41
2014
Q4 		$1.86M Buy
+184,720
New +$936K 1.46% 21

Other funds holding SRNE

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
B
Baird Milwaukee, Wisconsin $9.78B AUM 11.39% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sio Capital Management's SRNE Position: Q1 2015 in Review

Sio Capital Management sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2015, closing a stake of 184,720 shares — an estimated $1.86M sold.

Sio Capital Management first reported a position in SRNE in Q4 2014 and held it in 1 quarter. The position peaked at $1.86M in Q4 2014. 56 funds tracked by Wall St. Rank hold SRNE as of Q1 2015.

  • Sio Capital Management reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2015 after selling out during the quarter.
  • Sio Capital Management sold 184,720 Sorrento Therapeutics, Inc. shares in Q1 2015, an estimated $1.86M.
  • Sio Capital Management first reported a position in Sorrento Therapeutics, Inc. in Q4 2014 and held it in 1 quarter.
  • Sio Capital Management's Sorrento Therapeutics, Inc. position peaked at $1.86M in Q4 2014.
  • 56 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2015.

Based on Sio Capital Management's 13F filing for Q1 2015, filed 15 May 2015.